Parker Institute Showcases Pioneering Advances in Immunotherapy at SITC 2025 Annual Meeting At the 2025 SITC Annual Meeting, the Parker Institute for Cancer Immunotherapy highlights new advancements and honors key contributors in the field of cancer research.

Parker Institute Showcases Pioneering Advances in Immunotherapy at SITC 2025 Annual Meeting #USA #Cancer_Immunotherapy #National_Harbor #Parker_Institute #SITC_2025

Pilatus Biosciences Unveils Groundbreaking Data on PLT012 at SITC 2025 Annual Meeting At SITC 2025, Pilatus Biosciences reveals impressive findings on its lead candidate PLT012, showcasing its dual mechanism to combat solid tumors.

Pilatus Biosciences Unveils Groundbreaking Data on PLT012 at SITC 2025 Annual Meeting #Switzerland #Pilatus_Biosciences #PLT012 #Epalinges #SITC_2025

Compugen to Unveil Groundbreaking Cancer Immunotherapy Trial at SITC 2025 Compugen will present a pioneering clinical trial for the anti-IL18BP antibody COM503, aimed at advanced malignancies at SITC 2025.

Compugen to Unveil Groundbreaking Cancer Immunotherapy Trial at SITC 2025 #Israel #Compugen #Holon #COM503 #SITC_2025